Feng Guo

Feng Guo

Chief Executive Officer at
Genor Biopharma Co., Ltd.

Net worth: 3 M $ as of 2026-07-30

56 year
Health Technology
Consumer Services

Profile

Feng Guo is currently Chief Executive Officer at Genor Biopharma Co., Ltd. since 2020.
Former positions include Chief Executive Officer at Tayu Huaxia Biotech Medical Group Co Ltd from 2017 to 2018, Chief Executive Officer at Edding Genor Group Holdings Ltd. from 2024 to 2026, Associate Director-Pfizer Global R&D at Pfizer Inc. from 2002 to 2013, and Executive Director & Vice President at Sihuan Pharmaceutical Holdings Group Ltd. from 2017 to 2018.
Education includes a doctorate from the University of Toronto conferred in 2001.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-09-02 13,997,843 ( 0.7% ) 3 M $ 2026-07-30

Feng Guo active positions

CompaniesPositionStart
Chief Executive Officer 2020-03-31

Former positions of Feng Guo

CompaniesPositionEnd
EDDING GENOR GROUP HOLDINGS LIMITED Chief Executive Officer 2026-03-26
Tayu Huaxia Biotech Medical Group Co Ltd
Chief Executive Officer 2018-11-30
SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. Director/Board Member 2018-04-19
PFIZER INC. Corporate Officer/Principal 2013-03-31
See the detail of Feng Guo's experience

Training of Feng Guo

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

93

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Tayu Huaxia Biotech Medical Group Co Ltd